Clinical classification of regulatory variants in breast cancer susceptibility genes - NHMRC
Genetic testing of breast cancer susceptibility genes frequently identifies gene variants of uncertain clinical significance. Unclassified variants are a major clinical challenge as they complicate test reporting and genetic counselling, limit patient eligibility for intensive surveillance
and gene-targeted therapies, and prevent gene testing and guided management of relatives. This project will test the hypothesis that DNA sequence variants in well-annotated regulatory regions of multiple breast cancer susceptibility genes confer a significant increased risk of breast cancer.
The overall aim of this project is to develop clinically useful tools for the classification of sequence variants that map to regulatory regions of breast cancer susceptibility genes that are currently included in multi-cancer gene testing panels.Genetic testing of breast cancer susceptibility genes frequently identifies gene variants of uncertain clinical significance.
Unclassified variants are a major clinical challenge as they complicate test reporting and genetic counselling, limit patient eligibility for intensive surveillance and gene-targeted therapies, and prevent gene testing and guided management of relatives. This project will test the hypothesis that DNA sequence variants in well-annotated regulatory regions of multiple breast cancer susceptibility genes confer a significant increased risk of breast cancer. The overall aim of this project is to develop clinically useful tools for the classification of sequence variants that map to regulatory regions of breast cancer susceptibility genes that are currently included in multi-cancer gene testing panels.
The overall aim of this project is to develop clinically useful tools for the classification of sequence variants that map to regulatory regions of breast cancer susceptibility genes that are currently included in multi-cancer gene testing panels.Genetic testing of breast cancer susceptibility genes frequently identifies gene variants of uncertain clinical significance.
Unclassified variants are a major clinical challenge as they complicate test reporting and genetic counselling, limit patient eligibility for intensive surveillance and gene-targeted therapies, and prevent gene testing and guided management of relatives. This project will test the hypothesis that DNA sequence variants in well-annotated regulatory regions of multiple breast cancer susceptibility genes confer a significant increased risk of breast cancer. The overall aim of this project is to develop clinically useful tools for the classification of sequence variants that map to regulatory regions of breast cancer susceptibility genes that are currently included in multi-cancer gene testing panels.
Keywords: AUSTRALIA; BREAST CANCER; CANCER SUSCEPTIBILITY GENES; GENE REGULATION; GENE REGULATORY VARIANTS; GENES; GENOMICS; LEUKAEMIA; MUTATIONS
Document Type: Research Article
Publication date: 01 February 2017
Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.
- Subscribe to this Title
- Terms & Conditions
- Disseminating research in Impact
- Information about Impact
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content